Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
Description
Early in the COVID-19 pandemic, data suggested that males had a higher risk of developing severe disease and that androgen deprivation therapy might be associated with protection. Combined with the fact that TMPRSS2 (transmembrane serine protease 2)
